Planned enrollment increased by 18 participants
Before: 56 participants (planned). After: 74 participants (planned).
Study sponsor: Maze Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 56 participants (planned). After: 74 participants (planned).